Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Peptide challenges in affective illness.

R M Cohen, M R Cohen

Journal of Clinical Psychopharmacology

|July 1, 1981

Summary

This summary is machine-generated.

Certain peptides impact neuroendocrine and limbic systems, crucial in affective disorders. A blunted thyroid stimulating hormone (TSH) response to thyrotropin releasing hormone (TRH) may aid in diagnosing depression and mania.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Learning and attention reveal a general relationship between population activity and behavior.

Science (New York, N.Y.)·2018

Same author

Expression of anxiety and depression in a case of subcortical motor aphasia.

NeuroRehabilitation·2014

Same author

Point-of-care bar-coded medication administration: experience in the United States.

Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2005

Same author

Complete remodelling of displaced fractures of the neck of the phalanx.

The Journal of bone and joint surgery. British volume·2003

Same author

Medication errors.

Hospitals & health networks·2001

Same author

Herbal and complementary and alternative medicine therapies for liver disease. A focus on Chinese traditional medicine in hepatitis C virus.

Clinics in liver disease·2001

Same journal

Aripiprazole Withdrawal-Associated Restless Legs Syndrome During Clozapine Treatment in an Adolescent With Schizoaffective Disorder: A Case Report.

Journal of clinical psychopharmacology·2026

Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026

Same journal

Article Selected to Receive the Mitchell B. Balter Award for Publications in 2025.

Journal of clinical psychopharmacology·2026

Same journal

Pregnancy Outcomes After First-Trimester Exposure to Vortioxetine: Prospective Outcomes From the MGH National Pregnancy Registry for Psychiatric Medications.

Journal of clinical psychopharmacology·2026

Same journal

Salute to Our Reviewers.

Journal of clinical psychopharmacology·2026

Same journal

Serotonin Syndrome Associated With Polypharmacy in an Elderly Patient With Dementia and Parkinson Disease.

Journal of clinical psychopharmacology·2026

See all related articles

Area of Science:

Neuroendocrinology
Psychiatry
Pharmacology

Background:

Neuroendocrine and limbic systems are vital for regulating functions, with disturbances noted in affective disorders.
Several peptides, including TRH, LHRH, MIF-I, and DDAVP, have been administered to patients with affective illnesses.
Previous research indicates potential alterations in the central nervous system-anterior pituitary axis in affective disorders.

Purpose of the Study:

To investigate the role of specific peptides in the functioning of neuroendocrine and limbic systems.
To explore the diagnostic potential of peptide administration in affective disorders.
To examine the physiological relationship between the central nervous system and the anterior pituitary in affective illness.

Main Methods:

Related Experiment Videos

Administration of specific peptides (TRH, LHRH, MIF-I, DDAVP) to affectively ill patients.

Measurement of thyroid stimulating hormone (TSH) response to TRH administration.

Observation of behavioral effects following peptide administration.

Main Results:

A blunted TSH response to TRH was observed in some patients with depression, mania, and alcoholism.
The blunted TSH response (≤5 microU/ml) may serve as a diagnostic indicator for depression and mania.
Peptides TRH, LHRH, DDAVP, and MIF-I demonstrated general activating behavioral effects in humans.

Conclusions:

The blunted TSH response to TRH suggests significant alterations in CNS-pituitary function in affective disorders.
This blunted response could be a valuable diagnostic tool for depression and mania.
Further research is needed to clarify the specific roles and potential of peptide challenges in studying affective illness, considering limitations in sample size and peptide action sites.